Avadel Pharmaceuticals Financial Overview
Avadel Pharmaceuticals's market cap is currently $2.11B. The company's EPS TTM is $0; its P/E ratio is -3,925.45; Avadel Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.10. See an overview of income statement, balance sheet, and cash flow financials.
